The 20 Best Hypophosphatasia (HPP) Doctors in Maryland, US

Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy.

Harpreet Bhutani is a Nephrologist in Takoma Park, Maryland. Dr. Bhutani is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Childhood Hypophosphatasia (HPP).

Muneeb Malik is a Nephrologist in Frederick, Maryland. Dr. Malik is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Diabetic Nephropathy, and Acute Kidney Failure.

Sandesh Joshi is a Nephrologist in Rockville, Maryland. Dr. Joshi is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, Necrosis, and Endoscopy.

Mohammad Khan is a Nephrologist in Chevy Chase, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.

Tin Maung is a Nephrologist in Columbia, Maryland. Dr. Maung is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Acute Kidney Failure.

Ping-hsin Chen is a Nephrologist in Columbia, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Renovascular Hypertension, Acute Kidney Failure, Acute Tubular Necrosis, and Nephrosclerosis.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Mary Pieprzak is a Nephrologist in Columbia, Maryland. Dr. Pieprzak is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.

Jagdeep Obhrai is a Nephrologist in Chevy Chase, Maryland. Dr. Obhrai is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, Nephrosclerosis, and Kidney Transplant.

Farah Abifaraj is a Nephrologist in Baltimore, Maryland. Dr. Abifaraj is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), High Potassium Level, and Hypophosphatasia (HPP).

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Low Potassium Level, and Kidney Transplant.

Dr. David Valle is a professor of pediatrics and ophthalmology at the Johns Hopkins School of Medicine and former director of the Johns Hopkins Department of Genetic Medicine. He also serves as a geneticist for the Johns Hopkins Children’s Center. Dr. Valle holds a bachelor’s degree and medical degree from Duke University. He completed a pediatric residency at Johns Hopkins University before joining the Johns Hopkins faculty. He is interested in the genetic contributions to health and disease. He is the founding director of the Johns Hopkins Center for Inherited Disease Research. Over the years, his laboratory has discovered the genetic causation for more than 20 diseases, including those responsible for inborn errors of metabolism, inherited retinal degeneration, disorders of cellular organelle biogenesis and genetic variations that contribute risk for common disorders such as schizophrenia. Dr. Valle also serves as director of the Predoctoral Training Program in Human Genetics, as well as co-director of the Genes to Society program. He was a 2014 recipient of the annual Victor A. McKusick Leadership Award from the American Society of Human Genetics, which recognizes individuals whose professional achievements have fostered and enriched the development of human genetics as well as its assimilation into the broader context of science, medicine and health. Dr. Valle is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Spondyloepimetaphyseal Dysplasia Strudwick Type, Micrognathia, Urea Cycle Disorders (UCD), and Spondyloepiphyseal Dysplasia Congenita.

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Exocrine Pancreatic Insufficiency, Familial Glucocorticoid Deficiency, and Hormone Replacement Therapy (HRT).

Ali Ghorbani is a Nephrologist in Takoma Park, Maryland. Dr. Ghorbani is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Childhood Hypophosphatasia (HPP).

Adnan Hashmi is a Nephrologist in Annapolis, Maryland. Dr. Hashmi is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Necrosis.

Saeed Kronfli is a Nephrologist in Takoma Park, Maryland. Dr. Kronfli has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Hypophosphatemia.

Dr. Jeremy A. Marcus is a nephrologist affiliated with Sibley Memorial Hospital, Georgetown University Hospital, Washington Hospital Center and George Washington University Hospital, where he serves as an assistant professor of medicine for the George Washington University School of Medicine. He practices out of Washington Nephrology Associates in Washington, D.C. Dr. Marcus earned his medical degree from the University of Rochester School of Medicine and Dentistry. He completed an internship and residency in internal medicine at Beth Israel Deaconess Medical Center, where he also served as chief resident and clinical instructor of medicine. Dr. Marcus completed a fellowship in nephrology at Tufts-New England Medical Center. Dr. Marcus is a member of the American College of Physicians. Dr. Marcus is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Polycystic Kidney Disease.

Ziad Khoury is a Nephrologist in Chevy Chase, Maryland. Dr. Khoury is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Familial Hypocalciuric Hypercalcemia Type 1.

Dr. Steven A. Burka is a nephrologist affiliated with Sibley Memorial Hospital and Suburban Hospital. He has a private practice in Chevy Chase, Md. Dr. Burka earned his medical degree from George Washington University School of Medicine. He completed a residency in internal medicine at Beth Israel Medical Center, followed by residencies in nephrology at Bellevue Hospital Center and New York University Medical Center. Dr. Burka was named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly in 2012. Videos 2017 Best Consulting Physician at Sibley Memorial Hospital - Steven Burka, M.D. Dr. Burka is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Chronic Kidney Disease, High Potassium Level, End-Stage Renal Disease (ESRD), and Low Sodium Level.